Meretoja, Atte, Acciarresi, Monica, Sato, Shoichiro, Wu, Bo, Brainin, Michael, Norrving, Bo, Davis, Stephen, Akinyemi, Rufus O., Campbell, Bruce, Dowlatshahi, Dar, English, Coralie, Henninger, Nils, Poppe, Alexandre, Putaala, Jukka, Saini, Monica. Sage; 2017. Stroke doctors: who are we? A World Stroke Organization survey.

Meretoja, Atte, Keshtkaran, Mahsa, Saver, Jeffrey L., Tatlisumak, Turgut, Parsons, Mark W., Kaste, Markku, Davis, Stephen M., Donnan, Geoffrey A., Churilov, Leonid. Lippincott Williams & Wilkins; 2014. Stroke thrombolysis: save a minute, save a day.

Campbell, Bruce C. V., Mitchell, Peter J., Parsons, Mark W., Wu, Teddy Y., Brooks, Mark, Simpson, Marion A., Miteff, Ferdinand, Levi, Christopher R., Krause, Martin, Harrington, Timothy J., Faulder, Kenneth C., Steinfort, Brendan S., Churilov, Leonid, Ang, Timothy, Scroop, Rebecca, Barber, P. Alan, McGuinness, Ben, Wijeratne, Tissa, Phan, Thanh G., Chong, Winston, Chandra, Ronil V., Bladin, Christopher F., Rice, Henry, Keshtkaran, Mahsa, de Villiers, Laetitia, Ma, Henry, Desmond, Patricia M., Meretoja, Atte, Cadilhac, Dominique A., Donnan, Geoffrey A., Davis, Stephen M., Hong, Keun-Sik, Kleinig, Timothy J., Dewey, Helen M., Yassi, Nawaf, Yan, Bernard, Dowling, Richard J.. Frontiers Research Foundation; 2017. Endovascular thrombectomy for ischemic stroke increases disability-free survival, quality of life, and life expectancy and reduces cost.

Campbell, Bruce C. V., Yassi, Nawaf, Donnan, Geoffrey A., Davis, Stephen M., Ma, Henry, Sharma, Gagan, Salinas, Simon, Churilov, Leonid, Meretoja, Atte, Parsons, Mark W., Desmond, Patricia M., Lansberg, Maarten G.. Sage; 2015. Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis.

Meretoja, Atte, Yassi, Nawaf, Wu, Teddy Y., Churilov, Leonid, Sibolt, Gerli, Jeng, Jiann-Shing, Kleinig, Timothy, Spratt, Neil J., Thijs, Vincent, Wijeratne, Tissa, Cho, Der-Yang, Shah, Darshan, Cloud, Geoffrey C., Phan, Thanh, Bladin, Christopher, Moey, Andrew, Aviv, Richard I., Barras, Christen D., Sharma, Gagan, Hsu, Chung Y., Levi, Christopher, Ma, Henry, Campbell, BCV, Mitchell, P, Yan, B, Parsons, MW, Tiainen, M, Curtze, S, Strbian, D, Tang, SC, Harvey, J, Donnan, GA, Davis, SM. The Lancet Publishing Group; 2020. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.

Bladin, Christopher F., Wah Cheung, Ngai, Parsons, Mark W., Meretoja, Atte, Tiainen, Marjaana, Choi, Philip M. C., Cordato, Dennis, Brown, Helen, Campbell, Bruce C. V., Davis, Stephen M., Cloud, Geoffrey, Grimley, Rohan, Dewey, Helen M., Lee-Archer, Matthew, Ghia, Darshan, Sanders, Lauren, Markus, Romesh, Muller, Claire, Salvaris, Patrick, Wu, Teddy, Fink, John, TEXAIS Investigators,, Churilov, Leonid, Middleton, Sandy, Thijs, Vincent, Ekinci, Elif, Levi, Christopher R., Lindley, Richard, Donnan, Geoffrey A.. Lippincott Williams & Wilkins; 2023. Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial.

Bivard, Andrew, Churilov, Leonid, Davis, Stephen, Donnan, Geoffrey, Yan, Bernard, Parsons, Mark, Ma, Henry, Levi, Christopher, Campbell, Bruce, Yassi, Nawaf, Meretoja, Atte, Zhao, Henry, Sharma, Gagan, Chen, Chushuang. Wiley-Blackwell; 2022. Does variability in automated perfusion software outputs for acute ischemic stroke matter? Reanalysis of EXTEND perfusion imaging.

Yassi, Nawaf, Zhao, Henry, Jeng, Jiann-Shing, Choi, Philip M. C., Duc, Phuc Dang, Brown, Helen, Ranta, Annemarei, Spratt, Neil, Cloud, Geoffrey C., Wang, Hao-Kuang, Grimley, Rohan, Mahawish, Karim, Churilov, Leonid, Cho, Der-Yang, Shah, D, Nguyen, TMP, Sharma, G, Yogendrakumar, V, Yan, B, Harrison, EL, Devlin, M, Cordato, D, Martinez-Majander, N, Wu, Teddy Y., Strbian, D, Thijs, V, Sanders, LM, Anderson, D, Parsons, MW, Campbell, BCV, Donnan, GA, Davis, SM, Ma, Henry, Nguyen, Huy-Thang, Cheung, Andrew, Meretoja, Atte, Mai, Duy Ton, Kleinig, Timothy. The Lancet Publishing Group; 2024. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.